N-((23S,26S)-23,27-dicyclohexyl-1-(4-(methoxymethyl)-1H-1,2,3-triazol-1-yl)-22,25-dioxo-3,6,9,12,15,18-hexaoxa-21,24-diazaheptacosan-26-yl)isoxazole-5-carboxamide

ID: ALA4778041

Chembl Id: CHEMBL4778041

PubChem CID: 162644186

Max Phase: Preclinical

Molecular Formula: C39H65N7O11

Molecular Weight: 807.99

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COCc1cn(CCOCCOCCOCCOCCOCCOCCNC(=O)[C@@H](NC(=O)[C@H](CC2CCCCC2)NC(=O)c2ccno2)C2CCCCC2)nn1

Standard InChI:  InChI=1S/C39H65N7O11/c1-50-30-33-29-46(45-44-33)15-17-52-19-21-54-23-25-56-27-26-55-24-22-53-20-18-51-16-14-40-39(49)36(32-10-6-3-7-11-32)43-37(47)34(28-31-8-4-2-5-9-31)42-38(48)35-12-13-41-57-35/h12-13,29,31-32,34,36H,2-11,14-28,30H2,1H3,(H,40,49)(H,42,48)(H,43,47)/t34-,36-/m0/s1

Standard InChI Key:  ZOKSBQKEZDOZHE-GIWKVKTRSA-N

Alternative Forms

  1. Parent:

    ALA4778041

    ---

Associated Targets(Human)

F2RL1 Tchem Proteinase-activated receptor 2 (703 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 807.99Molecular Weight (Monoisotopic): 807.4742AlogP: 2.46#Rotatable Bonds: 31
Polar Surface Area: 208.65Molecular Species: NEUTRALHBA: 15HBD: 3
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.43CX Basic pKa: CX LogP: 1.66CX LogD: 1.66
Aromatic Rings: 2Heavy Atoms: 57QED Weighted: 0.09Np Likeness Score: -0.94

References

1. Majewski, Mark W., Gandhi, Disha M., Holyst, Trudy, Wang, Zhengli, Hernandez, Irene, Rosas, Ricardo, Zhu, Jieqing, Weiler, Hartmut, Dockendorff, Chris.  (2020)  Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin alphaVbeta3 and PAR2,  11  (8): [PMID:33479689] [10.1039/d0md00098a]

Source